Biaca, Miguel T.

HRN: 26-78-90  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/10/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/10/2025
03/23/2025
IV
4.5
Q8H
Sepsis Secondary To GI Pathology
Waiting Final Action 
03/17/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/17/2025
03/24/2025
IVT
4.5g
Q6
CAP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: